专题：Gastrointestinal Tumor Research and Treatment

This cluster of papers focuses on the diagnosis and treatment of gastrointestinal stromal tumors (GISTs), including the efficacy and safety of targeted therapies like Imatinib Mesylate and Sunitinib, the role of PDGFRA and KIT mutations in GISTs, consensus approaches for management, surgical considerations, prognostic factors, use of EUS-guided fine needle aspiration, and the significance of succinate dehydrogenase (SDH) deficiency. It also explores the use of PET imaging for response evaluation.
最新文献
Operative versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-Term Results

book-chapter Full Text OpenAlex

COL8A1 Regulates Esophageal Squamous Carcinoma Proliferation and Invasion Through PI3K/AKT Pathway

article Full Text OpenAlex

Enhancing treatment strategies for small bowel cancer: a clinical review of targeted therapy and immunotherapy approaches

review Full Text OpenAlex

Development of a multi-phase CT-based radiomics model to differentiate heterotopic pancreas from gastrointestinal stromal tumor

article Full Text OpenAlex

PRIMARY FOLLICULAR LYMPHOMA OF THE DUODENUM AS AN INCIDENTAL FINDING ON UPPER GASTROINTESTINAL ENDOSCOPY

article Full Text OpenAlex

Pancreatic Extragastrointestinal Stromal Tumor: A Case Report

article Full Text OpenAlex

CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer

article Full Text OpenAlex

Clinical characteristics and prognostic analysis of postoperative recurrence or metastasis of low-risk gastrointestinal stromal tumors

article Full Text OpenAlex

Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)

article Full Text OpenAlex

Machine learning-based radiomics score improves prognostic prediction accuracy of stage II/III gastric cancer: A multi-cohort study

article Full Text OpenAlex

近5年高被引文献
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

article Full Text OpenAlex 2580 FWCI353.56960959

Current treatment and recent progress in gastric cancer

review Full Text OpenAlex 1647 FWCI243.73132667

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

article Full Text OpenAlex 1584 FWCI322.9147705

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 1529 FWCI315.13388112

Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)

article Full Text OpenAlex 969 FWCI195.88295861

Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial

article Full Text OpenAlex 668 FWCI137.28198982

Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022

article Full Text OpenAlex 575 FWCI117.20193758

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

article Full Text OpenAlex 554 FWCI77.37093266

Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021

article Full Text OpenAlex 499 FWCI81.77427424

ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding

article Full Text OpenAlex 484 FWCI75.54998565